Watch our new video introducing the Catapult programme, its centres and crucial work
How Catapults are working today, for tomorrow
Related news
news
PACE provides funding and s...
PACE (Pathways to Antimicrobial Clinical Efficacy) has today launched its second funding round with up…
news
Cross-sector initiative pro...
The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has today announced the first cohort of…
news
A partnership between ERS G...
ERS Genomics Limited (ERS), the CRISPR licensing Company, and Medicines Discovery Catapult (MDC) have signed…
news
MDC maintains its high impa...
Medicines Discovery Catapult (MDC) Limited’s Annual Report for the year ended 31 March 2024 is…
news
Syndicate recognised for pu...
The Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate has achieved the Gold Standard from the…
news
The investigative study wil...
A researcher from the University of Liverpool (UoL) will benefit from Medicines Discovery Catapult’s (MDC)…
news
The partnership will play a...
The partnership will play a vital role in supporting advances in transformative drug discovery for patient benefit
news
Industry partners are invit...
Expressions of interest are invited from industry partners to develop and launch the recently announced…
news
New report says the sector ...
A new report released today by Medicines Discovery Catapult (MDC), in partnership with the UK…
news
One Nucleus acknowledges MD...
Medicines Discovery Catapult (MDC) received the award for ‘Non-Profit Life Science Innovation Enablers’ at last…
news
MDC will steer the set-up o...
Medicines Discovery Catapult (MDC) has been appointed as a Delivery Partner of the UK Government’s…
news
‘No Time Like the Present’ – ...
MDC engages with young people to share the importance of life sciences during British Science Week 2024
news
Scientists from the Univers...
Scientists from the University of Nottingham, in collaboration with Medicines Discovery Catapult (MDC), have been…
news
Medicines Discovery Catapul...
The annual International Day of Women and Girls in Science (11 February) was established nine…
news
Local college students enjo...
Medicines Discovery Catapult (MDC) has welcomed students from The Trafford College Group’s Cheadle campus to…
news
A report from the UK BioInd...
Today’s latest Genomics nation report shows the UK on the cusp of a new era…
news
Medicines Discovery Catapul...
The outputs of a year-long project that has brought together leading researchers, clinicians, industry experts…
news
The OBN Awards celebrate in...
Medicines Discovery Catapult (MDC) was named winner of the Best Industry Support Partner of the…
news
New £30m Initiative to Address Glo...
Pioneering partnership to drive development of new tests and treatments to tackle deadly antimicrobial resistance, which could otherwise kill 10 million a year by 2050
news
Continuing to Deliver Impac...
Medicines Discovery Catapult Limited’s (MDC) Annual Report for the year ended 31 March 2023 is…
news
Patients to benefit from ga...
A partnership between Medicines Discovery Catapult (MDC), the Medical Research Council (MRC) and Innovate UK…
news
MDC Welcomes Chancellor’s Call fo...
Medicines Discovery Catapult’s statement in response to the Chancellor of the Exchequer’s Mansion House speech…
news
Catapults and Leading Unive...
Catapults and Leading Universities Across the UK to Establish Brand New Intracellular Drug Delivery Centre
news
MDC will help Accelerate@Ba...
The annual Accelerate@Babraham start-up competition, run by the Cambridge-based Babraham Research Campus, has announced its…
news
Medicines Discovery Catapul...
April 2023 marks five years since Medicines Discovery Catapult (MDC), an independent, not-for-profit national innovation…
news
Your feedback will be inval...
Medicines Discovery Catapult (MDC), the Association of the British Pharmaceutical Industry (ABPI) and the Bioindustry…
news
The Bionow Awards celebrate...
The Psychiatry Consortium was named winner of the Partnership and Collaboration Award at last night’s…
news
Funding New Antimicrobials ...
Today (16 March 2023), Cystic Fibrosis (CF) Syndicate in Antimicrobial Resistance (AMR) announces a £3…
news
Medicines Discovery Catapul...
The life sciences sector is among the most valuable and strategically important to the UK…
news
Shining a spotlight on a se...
To celebrate International Day of Women and Girls in Science, Medicines Discovery Catapult (MDC) is…
news
Medicines Discovery Catapul...
Medicines Discovery Catapult (MDC) and SMi have secured a Biomedical Catalyst (BMC) grant to validate…
news
Company plans to triage a p...
Alchemab Therapeutics, a biotechnology company unlocking new therapies from within the immune system, today announced…
news
Andrea Stott joins Medicine...
Andrea’s career spans a variety of sectors, including global pharma, manufacturing, utilities, consumer, legal and…
news
Accelerating medicines disc...
The costs of treating ageing and age-related conditions are significant. In the UK, the cost…
news
Catapult Network Support Confirmed ...
The Chancellor of the Exchequer’s Autumn Statement to Parliament has confirmed long-term support for the…
news
Prestigious industry awards...
We are delighted to announce that Medicines Discovery Catapult’s CEO, Professor Chris Molloy, has received…
news
Innovate UK SMART Grant awa...
Medicines Discovery Catapult (MDC) and Xerion Healthcare have been awarded Innovate UK SMART Grant funding…
news
New appointment reflects am...
Volker Hirsch has joined Medicines Discovery Catapult (MDC) as Chief Commercial Officer to direct the…
news
School engagement programme...
Scientists from Medicines Discovery Catapult (MDC) have visited schools across Cheshire to deliver interactive lessons…
news
Pivotal partnership seeks t...
LifeArc, a national medical research charity, is joining the Cystic Fibrosis (CF) Antimicrobial Resistance (AMR)…
news
Medicines Discovery Catapul...
Shionogi & CO., LTD. (known as “Shionogi”), a leading global research-driven pharmaceutical company, has joined…
news
Driving the application of ...
Medicines Discovery Catapult (MDC) and ZEISS have joined forces to improve drug discovery and early…
news
New report from UK BioIndus...
Genomics companies outperform their life science peers at attracting both public and private investment, according…
news
Medicines Discovery Catapul...
Exploring the theme of ‘lifting the limits together’, this week (13-19 June) marks Cystic Fibrosis…
news
Alderley Park conference ai...
Medicines Discovery Catapult (MDC) is hosting UK SPINE, ‘Healthspan vs. lifespan: New medicines to close…
news
House of Lords Recognises Catapult ...
Last week the Catapult Network was highlighted as unique and critical national innovation assets by…
news
Medicines Discovery Catapult Applau...
March 2022 marks two years since the UK government called upon Medicines Discovery Catapult (MDC)…
news
Partnership Set to Inspire ...
Medicines Discovery Catapult (MDC) has partnered with the Cheshire and Warrington LEP for a school…
news
Alchemab Extends Partnership with M...
Alchemab Therapeutics – a biotechnology company focused on the discovery and development of naturally-occurring protective…
news
Catapult Network Confirms Commitmen...
The Catapult Network this week (24th February 2022) formalised its long-held commitment to Equality, Diversity…
news
Leading Scientists Share Ad...
11 February 2022 marks the seventh International Day of Women and Girls in Science. In…
news
Alderley Park Lighthouse Laboratory...
From the first steam-powered mill and the splitting of the atom, to the invention of…
news
The Alderley Park Lighthous...
The Laboratory, which is part of the largest diagnostic project in British history, launched in…
news
Medicine Discovery Catapult’s Psy...
The University of Trento and the University of Bologna are collaborating with global pharmaceutical companies…
news
Early Career Professional P...
Medicines Discovery Catapult (MDC) scientist, Dr Lauren Toms, has won the Early Career Professional Poster…
news
As schoolchildren return fr...
Testing plays a key role in our effort to fight and contain COVID-19; helping…
news
Quantum Computing in drug discovery...
Innovate UK grant awarded for development of quantum computing in cancer treatment
news
Dr Nisha Ponnappan, Postdoc...
A Medicines Discovery Catapult (MDC) scientist has landed the award for ‘Best Poster’ at the ELRIG Drug Discovery Conference 2021.
news
Psychiatry medicines discovery cham...
Dr. Laura Ajram, Psychiatry Consortium Programme Manager at Medicines Discovery Catapult (MDC) has landed the…
news
Medicines Discovery Catapul...
Following an extensive international search, the MDC Board unanimously came to the decision that Chris…
news
Medicines Discovery Catapul...
Prior to commencing his role as MDC Chairman in 2018, Robin was Chief Executive Officer…
news
Medicines Discovery Catapult and We...
Medicines Discovery Catapult (MDC) and We Share Ventures have embarked on a joint venture, piloting…
news
Medicines Discovery Catapult relaun...
Medicines Discovery Catapult (MDC) today announces the relaunch of radiochemistry at the Wolfson Molecular Imaging…
news
New report reveals strength of the ...
New report reveals strength of the UK’s thriving genomics sector The BioIndustry Association (BIA), the…
news
Catapult Network welcomes Governmen...
The Catapult Network welcomes the launch of the Government’s Innovation Strategy. The Catapult Network is…
news
No code, no problem: Chief.AI and M...
Chief.AI, in partnership with Medicines Discovery Catapult (MDC), has launched the first no-code, pay as…
news
Medicines Discovery Catapult welcom...
Medicines Discovery Catapult (MDC) is proud to announce an extension to its talented workforce, further…
news
MDC Seeks Buyer for Alderley Park L...
Medicines Discovery Catapult (MDC) today (8 July 2021) announces its intention to sustain its Alderley…
news
Complex Medicines: Targeted drug tr...
A new report published by Medicines Discovery Catapult and CPI details the huge medical and…
news
MDC Lighthouse Lab Recognised for ...
The Medicines Discovery Catapult (MDC) Lighthouse Lab in Cheshire, which has played a vital role…
news
£13m Translational Research Facili...
The UK’s centre for therapeutics innovation, Medicines Discovery Catapult (MDC), has received a £5 million…
news
Medicines Discovery Catapult CEO to...
Chris Molloy, Chief Executive Officer of the Medicines Discovery Catapult will be stepping down in…
news
Accelerated and more efficient drug...
Psychiatric drug discovery must be a truly collaborative process if it is to be successful.…
news
MDC Lighthouse Lab Partner With Lev...
While student perceptions of careers in science may come with a lack of diversity, the…
news
Drug Discovery Leader Dr Nicola Her...
Medicines Discovery Catapult’s newly appointed Chief Business Officer, Dr Nicola Heron MBA sets out her…
news
Fighting the Pandemic and the Glass...
Ahead Of International Day Of Women And Girls In Science, Three Covid Scientists Share Their…
news
Recognition for Manchester scientis...
Staff and students at the University of Manchester have been recognised for their role in…
news
Investigating new treatment for sch...
A partnership between the University of Oxford, the Earlham Institute, and the global pharmaceutical companies…
news
Testing Lab Data Reveals Spread of ...
Scientists at the Alderley Park Lighthouse Lab in Cheshire have revealed the speed and scale…
news
Alderley Park Lighthouse Lab Proces...
Scientists at the Alderley Park Lighthouse Lab in Cheshire processed their 6 millionth test over…
news
Cheshire’s COVID Christmas Ch...
Shining a spotlight on the region’s scientists who will be working throughout the festive period…
news
UK Innovators Target Nanoparticles ...
Active Needle Technology, Xerion Healthcare and Medicines Discovery Catapult win funding to begin ground-breaking project…
news
Biology 2.0: Combining machine-lear...
Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules…
news
Innovate UK Funded Project Produces...
Optibrium, Intellegens and Medicines Discovery Catapult combine their expertise in drug discovery and AI research…
news
UK innovation and technology centre...
The Catapult Network launched today the 2019-2020 Annual Report – Creating the future through innovation:…
news
Covid testing pioneer named as a Bi...
Dr Sally Price, Head of Cell and Translational Science at Medicines Discovery Catapult (MDC) has…
news
University of Exeter and Medicines ...
Today, the University of Exeter and Medicines Discovery Catapult (MDC) announce their strategic partnership to…
news
Boost for Mental Health Medicines R...
Global mental health care company, COMPASS Pathways has joined the Psychiatry Consortium, bringing additional expertise…
news
North West Lab Reaches Testing Mile...
The Alderley Park Lighthouse Lab in Cheshire, which plays a key role in the UK…
news
Bruntwood Scitech’s Alderley Park...
The national programme, to develop and progress start-up oncology projects, is being launched by Bruntwood…
news
UK SPINE: Healthy ageing programme ...
National UK SPINE initiative created to help us stay healthy in later years Innovative research…
news
A Beacon of Light for Employment: A...
The Alderley Park Lighthouse Lab in Cheshire plays a key role in supporting the government’s…
news
Oncimmune and Medicines Discovery C...
Validated research tool to be used to predict disease severity and individual therapeutic response to…
news
Innovate UK funding for new precisi...
Sixfold Bioscience and Medicines Discovery Catapult (MDC) awarded Innovate UK grant to pursue ground-breaking project…
news
Medicines Discovery Catapult expand...
Today, Medicines Discovery Catapult (MDC) announce the rapid expansion of its Biosamples supply network, creating…
news
Medicines Discovery Catapult awarde...
Today (11th August 2020), Medicines Discovery Catapult (MDC) announce that it has been awarded government…
news
Cheshire East Council welcomes fund...
Cheshire East Council has welcomed the announcement on 4 August 2020, of £15.5 million of…
news
Alderley Park Lighthouse Laboratory...
The Alderley Park Lighthouse Lab, which was launched to rapidly expand COVID-19 testing capacity, has…
news
What makes a drug discovery consort...
Consortia are enabling drug discovery in areas that individual organizations are unable to support alone…
news
Psychiatry Consortium launches seco...
The Psychiatry Consortium is again seeking project proposals which focus on the validation of novel…
news
Medicines Discovery Catapult welcom...
This week the Medicines Discovery Catapult has welcomed three new Board Members. Alistair Macdonald, Graham…
news
Supporting the race for treatments ...
Medicines Discovery Catapult, Retrogenix and Peak Proteins collaborate to identify target receptors for COVID-19 Today…
news
Britain’s biggest network of diag...
Sites in Milton Keynes, Glasgow and Alderley Park in Cheshire are now live and are…
news
Testing capacity increases as secon...
The second mega-lab at Alderley Park in Cheshire has begun to test thousands of patient…
news
Health Secretary launches biggest d...
Health Secretary Matt Hancock has today (9th April 2020) officially opened the biggest diagnostic lab…
news
Medicines Discovery Catapult, at Al...
Last week the Government announced the establishment of large scale national COVID-19 hub laboratories across…
news
Boehringer Ingelheim Office Hours d...
Boehringer Ingelheim Office Hours dedicated to Hearing Loss: supporting entrepreneurial research on hearing therapeutics The…
news
Medicines Discovery Catapult celebr...
To celebrate British Science Week, Medicines Discovery Catapult have brought their most experienced scientists together…
news
Medicines Discovery Catapult welcom...
In response to the UK Government’s Budget 2020 , Chris Molloy, CEO of the Medicines Discovery Catapult said:…
news
Medicines Discovery Catapult Nurtur...
Medicines Discovery Catapult (MDC) have welcomed a cohort of MRC-funded PhD students as part of…
news
MDC celebrates International Day of...
To mark International Day of Women and Girls in Science, we are celebrating by highlighting…
news
Dr Martin Main Guest Editor of SLA...
The February special issue of SLAS Discovery, ‘Advances in Cellular Target Engagement and Target Deconvolution,’…
news
Catapult Network welcomes UK Govern...
In response to the UK Government’s announcement on investment in science, research and innovation in…
news
Medicines Discovery Catapult, use M...
Today (22nd January 2020) Medicines Discovery Catapult, alongside Incisive Health and use MY data published…
news
Hearing Medicines Discovery Syndica...
Today (9th January 2020), the charity Action on Hearing Loss and Medicines Discovery Catapult announce…
news
Psychiatry Consortium brings Charle...
World-leading drug discovery organisations Charles River Laboratories and Evotec join the Psychiatry Consortium as drug…
news
LUNAC Therapeutics led project awar...
Today (2nd December 2019) LUNAC Therapeutics (LUNAC), a UK based drug discovery company focused on…
news
Medicines Discovery Catapult finali...
Yesterday (28th November 2019) Medicines Discovery Catapult (MDC) was recognised at the Bionow Annual Awards…
news
Redx Pharma and Medicines Discovery...
Strategic collaboration will enable preclinical assessment and inform clinical development strategy for Redx’s Porcupine (RXC006)…
news
A new initiative to revitalise drug...
Today (3rd October 2019) the Psychiatry Consortium announces its first call for projects that focus…
news
Cystic Fibrosis Syndicate i...
Medicines Discovery Catapult has joined forces with the Cystic Fibrosis Trust to form the Cystic Fibrosis (CF) Syndicate…
news
Medicines Discovery Catapult, MQ: T...
Psychiatry Consortium to address unmet patient needs Today (18th June 2019) Medicines Discovery Catapult, MQ:…
news
Bringing the benefits of cutting-ed...
Medicines Discovery Catapult and Waters partner to support UK medicines discovery with advanced technology solutions…
news
New report unveils a thriving servi...
Driving innovation into state-of-the-art technologies such as Artificial Intelligence and Complex Cell Models is key…
news
Medicines Discovery Catapult and Li...
Today (9th May 2019), Medicines Discovery Catapult and LifeArc, leading forces driving UK innovation in…
news
NC3Rs Technologies to Tools (T2T) a...
Accelerating translation of more predictive cell models in drug discovery Today (7th May 2019), the…
news
‘Pay as you go’ Artificial Inte...
Chief.AI and Medicines Discovery Catapult awarded funding to make Artificial Intelligence accessible to all drug…
news
Leveraging the UK’s renowned cont...
Medicines Discovery Catapult’s Virtual R&D Discovery Services platform announce twenty-two partnerships Today (26th April 2019),…
news
Unrivalled imaging capabilities now...
Medicines Discovery Catapult integrates Alderley Park’s imaging services and expertise, further enhancing pre-clinical imaging capabilities…
news
EPSRC announces 75 new Centres for ...
The Engineering and Physical Sciences Research Council (EPSRC) has awarded a total of £446 million…
news
NHS Long Term Plan: making the NHS ...
As medicine advances, health needs change and society develops, the NHS has to continually move…
news
£1.3 billion investment in UK econ...
Today (5th December 2018) we were delighted to attend the launch of the UK Governments’…
news
Research Showcase launches new coll...
Medicines Discovery Catapult and the National Centre for the Replacement, Refinement & Reduction of Animals…
news
New collaboration will advance huma...
Medicines Discovery Catapult and the Medical Research Council (MRC) Centre for Drug Safety Science (CDSS)…
news
Dr Peter Simpson takes part in deba...
On 25th September 2018 our CSO, Dr Peter Simpson, took part in Insider Media’s New…
news
Funding for Artificial Intelligence...
Chancellor Philip Hammond has unveiled significant investment to advance artificial intelligence (AI) and data science…
news
£215 million additional investment...
Today (23rd October 2018) we are delighted to confirm that the UK Government has announced…
news
Overcoming bottlenecks in early dru...
Medicines Discovery Catapult and AstraZeneca collaborate to unlock the potential of Acoustic Mist Ionisation Mass Spectrometry…
news
Novel deep learning drug discovery ...
OptibriumTM, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery…
news
Dr Martin Main appointed to SLAS Di...
Our Head of Molecular Technologies, Dr Martin Main, has been invited to serve as a…
news
Innovate UK’s Women in Innovation...
Innovate UK, as part of UK Research and Innovation, is looking to support female rising…
news
Medicines Discovery Catapult appoin...
Medicines Discovery Catapult has appointed Dr Robin Brown as its new Chairman. The company has…
news
Mark Samuels letter published in Th...
On Saturday (14th July 2018) our CBSO, Mark Samuels, had a Letter to the Editor…
news
Hacking genetic drug data at the We...
Discovering new drugs, diagnostics, and biomarkers is a now a data science, generating a huge…
news
Chris Molloy awarded Membership of ...
Today (6th July 2018) our CEO, Chris Molloy, was awarded Membership of the Institute of…
news
Enabling UK infrastructure to accel...
Our CEO, Chris Molloy, discusses the role of Medicines Discovery Catapult within the UK as a…
news
If the blockbuster medicine is now ...
The latest edition of Pharmaphorum’s Deep Dive magazine “Future Pharma” focuses on the predictions for…
news
Robotics, artificial intelligence a...
Today (6th June 2018) Business Secretary Greg Clark launched the Rosalind Franklin Institute and announced…
news
Using real world data in drug disco...
Our CEO, Chris Molloy and our Precision Medicine Lead, James Peach, spoke to PharmaTimes about…
Uncategorised
Artificial intelligence as a weapon...
Our Chief Informatics Officer, Professor John Overington, supports Prime Minister Theresa May’s plans to use AI…
Uncategorised
Humans on a chip – the future for...
Medicines Discovery Catapult, the Centre for Drug Safety Sciences at the University of Liverpool and…
Uncategorised
The House of Lords first report eva...
Our CEO, Chris Molloy, responds to the findings and recommendations: “The Medicines Discovery Catapult welcomes…
Uncategorised
New business models and cultural ch...
Mark Samuels, our Chief Business & Strategy Officer, was recently profiled in PharmaTimes sharing his…
Uncategorised
Pharma R&D productivity: Discov...
Our CEO, Chris Molloy, has an article featured at Open Access Government. He discusses how…
Uncategorised
Second collaborative project launch...
Tissue Solutions and Medicines Discovery Catapult launch service to support UK companies and biobanks Human…
Uncategorised
Mark Samuels’ mission to acce...
Mark Samuels, our Chief Business & Strategy Officer, was recently interviewed by Pharmafield magazine on…
Uncategorised
The Medicines Discovery Catapult su...
New drug discovery research to tackle the growing health epidemic of antimicrobial resistance will soon…
Uncategorised
How our vital biotech community can...
UK pharma R&D productivity is at an all-time low, warns our CEO Chris Molloy, but it’s…
Uncategorised
CSO, Dr Peter Simpson, joins SLAS B...
SLAS (Society for Laboratory Automation and Screening) is a global community of more than 30,000 scientists—from…
Uncategorised
The State of the Drug Discovery Nat...
The Medicines Discovery Catapult and BioIndustry Association call on the R&D community to address five…
Uncategorised
CEO Chris Molloy shares his vision ...
Our Chief Executive Officer, Chris Molloy, explores how Medicines Discovery Catapult is supporting the community…
Uncategorised
Microbubbles could revolutionise th...
Cutting edge collaboration between Medicines Discovery Catapult and the University of Leeds takes microbubble technology…
Uncategorised
Mark Samuels joins board of the UK&...
The UK’s largest Clinical Research Facility (CRF), Manchester, has been strengthened by the election of…
Uncategorised
‘The rise of Corporate Ventur...
The new research published by the ABPI shows that the amount of capital invested alongside…
Uncategorised
Government’s Industrial Strategy ...
Chris Molloy responds to the Government’s Industrial Strategy White Paper “The Medicines Discovery Catapult welcomes…
Uncategorised
Medicines Discovery Catapult: Life ...
Medicines Discovery Catapult to play an enabling role in support of UK life sciences industrial…